Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PC P-42:5 or PC O-42:6)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003293 AN005392 High Fat Feeding Alters Circulating Triglyceride Profile by Decreasing SCD Activity and Depleting omega-3 Fatty Acids Blood Rat Hyperlipidemia University of Southern California LC-MS
ST002817 AN004584 Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics Heart Mouse Cardiomyopathy University of California, San Francisco LC-MS
ST002764 AN004498 Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort Blood Human Cancer Icahn School of Medicine at Mount Sinai LC-MS
ST002764 AN004499 Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort Blood Human Cancer Icahn School of Medicine at Mount Sinai LC-MS
ST002700 AN004376 Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics Blood Human Autism Columbia University LC-MS
ST002700 AN004377 Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics Blood Human Autism Columbia University LC-MS
ST002545 AN004192 Lipidomic profile of Toxoplasma gondii-infected mice (Positive mode MS) Blood Mouse Cachexia University of Virginia LC-MS
ST002438 AN003972 Ozone alters glycosphingolipid metabolism and exacerbates characteristics of asthma in mice Lung Mouse Asthma University of California, Davis LC-MS
ST002002 AN003265 A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 3) Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome Columbia University LC-MS
ST001843 AN002986 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) Blood Human Fatty liver disease University of California, Davis GC-MS
ST001843 AN002986 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) Liver Human Fatty liver disease University of California, Davis GC-MS
ST001815 AN002946 Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis Blood Human Arthritis University of Kansas GC-MS/LC-MS
ST001637 AN002677 A Metabolome Atlas of the Aging Mouse Brain Brain Mouse University of California, Davis GC-MS/LC-MS
ST001637 AN002678 A Metabolome Atlas of the Aging Mouse Brain Brain Mouse University of California, Davis GC-MS/LC-MS
ST001246 AN002070 TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes (part-I) Cultured cells Human Sudden infant death syndrome University of California, Davis LC-MS
ST001211 AN002018 Metabolomic Markers of Methotrexate Response, In Vitro Cultured cells Human University of Kansas GC-MS/LC-MS
ST001151 AN001899 4-day dietary effect of fast food vs Mediterranean diet to HDL lipidome Blood Human University of California, Davis LC-MS
ST000991 AN001617 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) Blood Human University of California, Davis LC-MS
ST000990 AN001616 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) Blood Human University of California, Davis LC-MS
ST000989 AN001615 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) Blood Human University of California, Davis LC-MS
ST000988 AN001614 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) Blood Human University of California, Davis LC-MS
ST000987 AN001613 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part V) Blood Human University of California, Davis LC-MS
ST000986 AN001612 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IV) Blood Human University of California, Davis LC-MS
ST000985 AN001611 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part III) Blood Human University of California, Davis LC-MS
ST000984 AN001610 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) Blood Human University of California, Davis LC-MS
ST000983 AN001609 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) Blood Human University of California, Davis LC-MS
ST000423 AN000671 Differences in mycoplasma growth due to different mediums Cells Mouse University of California, Davis LC-MS
ST000343 AN000555 Modification of metabolites by gut microbiota in response to diet Blood Rat University of California, Davis LC-MS
ST000339 AN000550 Metabolites in peritoneal macrophages and bone marrow derived macrophages Cells Mouse University of California, Davis LC-MS
ST000331 AN000529 Effects of Zinc on GI tract metabolites (Part 2: Prostate) Prostate Mouse University of California, Davis LC-MS
ST000330 AN000527 Effects of Zinc on GI tract metabolites Esophagus Mouse University of California, Davis LC-MS
ST000330 AN000528 Effects of Zinc on GI tract metabolites Esophagus Mouse University of California, Davis LC-MS
ST000329 AN000526 Minimal change disease and focal segmental sclerosis in urine Urine Human Kidney disease University of California, Davis LC-MS
ST000328 AN000523 Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) Colon Dog University of California, Davis LC-MS
ST000328 AN000523 Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) Duodenum Dog University of California, Davis LC-MS
ST000328 AN000523 Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) Ileum Dog University of California, Davis LC-MS
ST000328 AN000523 Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) Rectum Dog University of California, Davis LC-MS
ST000324 AN000516 Progesterone level effects on primary metabolites in uterus, blood, and ovaries (Part 3:Ovaries) Follicular fluid Cow University of California, Davis LC-MS
ST000321 AN000510 Effects of LGG on current drinkers gut metabolism Feces Mouse Alcoholism University of California, Davis LC-MS
ST000082 AN000133 Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of serum samples Blood Human Cancer University of California, Davis LC-MS
  logo